Covestro (1COV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Jul, 2026Executive summary
Group sales declined by 1.9% year-over-year to €6,729 million, mainly due to negative currency effects and lower volumes, partially offset by higher selling prices.
EBITDA surged 64.4% to €669 million, driven by improved margins from higher selling prices and lower raw material costs, despite increased energy costs.
Net income reached €120 million, reversing a net loss of €219 million in the prior year; earnings per share improved to €0.58 from €-1.16.
Free operating cash flow improved significantly to €-87 million from €-481 million, reflecting higher EBITDA and better working capital management.
Financial highlights
Gross profit increased to €1,246 million from €1,017 million year-over-year.
EBIT rose to €244 million from €-48 million, with income before taxes at €206 million versus €-130 million.
Cash flows from operating activities turned positive at €310 million, up from a negative €116 million.
Net financial debt increased by €127 million to €1,923 million as of June 30, 2026.
Equity rose by €326 million to €7,342 million, mainly due to net income and positive FX effects.
Outlook and guidance
EBITDA for 2026 is now forecast significantly above the prior year, with both main segments expected to outperform previous guidance.
Free operating cash flow and ROCE above WACC are projected to improve substantially.
Greenhouse gas emissions are expected between 3.9 and 4.5 million metric tons CO2 equivalents.
Global economic growth for 2026 is forecast at 2.5%, with APAC outpacing other regions at 4.2%.
Latest events from Covestro
- AGM approved all items as company advances digital, sustainable growth amid ongoing challenges.1COV
AGM 2025 - FY 2025 saw lower sales and earnings, but transformation and climate targets remain on track.1COV
Investor presentation - EBITDA fell 30.9% to €740m as strategic actions and XRG partnership offset weak demand.1COV
Q4 2025 (Media) - Sales and EBITDA declined, but strategic initiatives and cost savings support future growth.1COV
Q4 2025 - Sales and EBITDA fell in Q3 2025, with guidance cut and acquisitions advancing.1COV
Q3 2025 - ADNOC's €62/share offer and €1.17bn capital boost support growth, sustainability, and governance.1COV
Investor Update - Q3 volume growth offset price declines; FY 2024 outlook narrowed amid margin pressure.1COV
Q3 2024 - Volume growth offset by lower prices; earnings and guidance down, STRONG program and ADNOC talks underway.1COV
Q2 2024 - Stable EBITDA and volume growth offset price declines; XRG takeover and STRONG program drive outlook.1COV
Q4 2024